L. Tylicki

B. Rutkowski, L. Tylicki, 2015, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions.

B. Rutkowski, S. Lizakowski, L. Tylicki, 2012, Journal of nephrology.

Influence of Renin-Angiotensin System Blockers on Graft Function in Retrospective Analysis of Pairs of Renal Transplant Recipients From the Same Donor.

A. Dębska-Ślizień, L. Tylicki, A. Zakrzewska, 2018, Transplantation proceedings.

Direct renin inhibition – a promising strategy for renal protection?

B. Rutkowski, S. Lizakowski, L. Tylicki, 2013, Medical science monitor : international medical journal of experimental and clinical research.

Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease.

B. Rutkowski, S. Lizakowski, M. Renke, 2013, Polskie Archiwum Medycyny Wewnetrznej.

Low-dose dual blockade of the renin-angiotensin system in patients with primary glomerulonephritis.

B. Rutkowski, M. Renke, Z. Zdrojewski, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Renal Transplant Recipients.

A. Dębska-Ślizień, L. Tylicki, A. Zakrzewska, 2018, Transplantation proceedings.

Smoking as a Risk Factor for Renal Injury in Essential Hypertension

W. Hörl, B. Rutkowski, L. Tylicki, 2006, Nephron Clinical Practice.

Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis: pilot study.

B. Rutkowski, M. Renke, L. Tylicki, 2002, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Hypertensive Nephropathy – An Increasing Clinical Problem

B. Rutkowski, L. Tylicki, J. Manitius, 1999, Mineral and Electrolyte Metabolism.

The use of over-the-counter analgesics in patients with chronic kidney disease

B. Rutkowski, A. Dębska-Ślizień, M. Chmielewski, 2019, European Journal of Translational and Clinical Medicine.

Dietary supplement use among patients with chronic kidney disease.

B. Rutkowski, M. Chmielewski, L. Tylicki, 2018, Acta biochimica Polonica.

Prevalence and Hypertension Treatment Schedule in Hemodialysis Patients and Renal Transplant Recipients in 2006 and 2014/2016.

A. Dębska-Ślizień, L. Tylicki, P. Rutkowski, 2018, Transplantation proceedings.

Renal Allograft Protection with Angiotensin II Type 1 Receptor Antagonists

B. Rutkowski, Z. Zdrojewski, L. Tylicki, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease.

B. Rutkowski, S. Lizakowski, S. Małgorzewicz, 2012, American journal of hypertension.

Low-dose dual blockade of the renin–angiotensin system improves tubular status in non-diabetic proteinuric patients

B. Rutkowski, M. Renke, L. Tylicki, 2005, Scandinavian journal of urology and nephrology.

Analysis of Experiences in Preventing COVID-19 in Hemodialysis Centers of the North of Poland before the Era of Vaccination

A. Dębska-Ślizień, L. Tylicki, B. Biedunkiewicz, 2022, International journal of environmental research and public health.

Antioxidants: A Possible Role in Kidney Protection

W. Hörl, B. Rutkowski, L. Tylicki, 2003, Kidney and Blood Pressure Research.

No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients.

B. Rutkowski, D. Rachoń, A. Dębska-Ślizień, 2004, Mediators of inflammation.

Career Opportunities

B. Rutkowski, D. Rachoń, J. Myśliwska, 2002, Computer.

[Health awareness and cooperation with the patient in the therapeutic process in a population of patients with chronic kidney disease in the center of Gdansk].

B. Rutkowski, A. Dębska-Ślizień, L. Tylicki, 2017, Przeglad lekarski.

Persistent Post-COVID-19 Syndrome in Hemodialyzed Patients—A Longitudinal Cohort Study from the North of Poland

A. Dębska-Ślizień, L. Tylicki, Krzysztof Szabat, 2021, Journal of clinical medicine.

Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine

A. Dębska-Ślizień, M. Renke, P. Trzonkowski, 2022, Frontiers in Immunology.

[Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline].

B. Rutkowski, M. Renke, L. Tylicki, 2008, Przeglad lekarski.

Randomized Placebo-Controlled Study on the Effects of Losartan and Carvedilol on Albuminuria in Renal Transplant Recipients

B. Rutkowski, Z. Zdrojewski, L. Tylicki, 2006, Transplantation.

Dual blockade of the renin–angiotensin–aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: An open, controlled, randomized study

B. Rutkowski, M. Renke, L. Tylicki, 2008, Scandinavian journal of urology and nephrology.

Dual blockade of the renin-angiotensin-aldosterone system in renal disease: what is the future?

B. Rutkowski, T. Stompór, S. Lizakowski, 2014, Polskie Archiwum Medycyny Wewnetrznej.

Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study.

B. Rutkowski, S. Lizakowski, S. Małgorzewicz, 2014, Advances in medical sciences.

Natural Killer Cell Activity Unaffected by Ozonated Autohemotherapy in Patients with End-Stage Renal Disease on Maintenance Renal Replacement Therapy

B. Rutkowski, D. Rachoń, A. Dębska-Ślizień, 2004, The International journal of artificial organs.

Treatment of Hypertension in Renal Transplant Recipients in Four Independent Cross-Sectional Analyses

B. Rutkowski, A. Dębska-Ślizień, H. Garnier, 2018, Kidney and Blood Pressure Research.

Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endothelium.

B. Rutkowski, L. Tylicki, W. Lysiak-Szydlowska, 2004, Artificial organs.

Management of Renin-Angiotensin-Aldosterone System Blockade in Kidney Transplant Recipients.

B. Rutkowski, A. Dębska-Ślizień, H. Garnier, 2018, Transplantation proceedings.

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience

A. Dębska-Ślizień, L. Tylicki, P. Rutkowski, 2021, Medicina.

Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis.

B. Rutkowski, S. Lizakowski, A. Dębska-Ślizień, 2006, Archives of medical research.

Ozonetherapy in a dialyzed patient with calcific uremic arteriolopathy.

B. Rutkowski, T. Liberek, L. Tylicki, 2003, Kidney international.

Platelet function unaffected by ozonated autohaemotherapy in chronically haemodialysed patients.

B. Rutkowski, S. Lizakowski, A. Dębska-Ślizień, 2004 .

Platelet function unaffected by ozonated autohaemotherapy in chronically haemodialysed patients

B. Rutkowski, S. Lizakowski, A. Dębska-Ślizień, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Ozone Therapy Seems to be Safe, But is it Really Clinically Effective?

B. Rutkowski, L. Tylicki, 2004, The International journal of artificial organs.

Fistula function and dialysis adequacy during ozonotherapy in chronically hemodialyzed patients.

B. Rutkowski, L. Tylicki, A. Chamienia, 2004, Artificial organs.

Clinical Efficacy of Ozonated Autohemotherapy in Hemodialyzed Patients with Intermittent Claudication: An Oxygen-Controlled Study

B. Rutkowski, L. Tylicki, T. Niewęgłowski, 2004, The International journal of artificial organs.

Beneficial Clinical Effects of Ozonated Autohemotherapy in Chronically Dialysed Patients with Atherosclerotic Ischemia of the Lower Limbs - Pilot Study

B. Rutkowski, B. Rutkowski, L. Tylicki, 2001, The International journal of artificial organs.

The Influence of Ozonated Autohemotherapy on Oxidative Stress in Hemodialyzed Patients with Atherosclerotic Ischemia of Lower Limbs

B Rutkowski, B. Rutkowski, A. Dębska-Ślizień, 2003, The International journal of artificial organs.

Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients

A. Dębska-Ślizień, L. Tylicki, J. Gołębiewska, 2021, Vaccines.

Multifactorial Determination of Hypertensive Nephroangiosclerosis

W. Hörl, B. Rutkowski, L. Tylicki, 2003, Kidney and Blood Pressure Research.

Extremely high mortality in COVID-19 hemodialyzed patients before the anti-SARS-CoV-2 vaccination era. Large database from the North of Poland

B. Rutkowski, A. Dębska-Ślizień, L. Tylicki, 2021 .

Renoprotective Effect of Small Doses of Losartan and Enalapril in Patients with Primary Glomerulonephritis

B. Rutkowski, M. Renke, L. Tylicki, 2002, American Journal of Nephrology.

Treatment of hypertension in renal transplant recipients

W. Hörl, A. Habicht, L. Tylicki, 2003, Current opinion in urology.

Humoral response to SARS-CoV-2 vaccination promises to improve the catastrophic prognosis of hemodialysis patients as a result of COVID-19. The COViNEPH Project.

A. Dębska-Ślizień, L. Tylicki, B. Biedunkiewicz, 2021, Polish archives of internal medicine.

Predictors of Mortality in Hemodialyzed Patients after SARS-CoV-2 Infection

A. Dębska-Ślizień, L. Tylicki, Krzysztof Szabat, 2022, Journal of clinical medicine.

Predictors of Humoral Response to mRNA COVID19 Vaccines in Kidney Transplant Recipients: A Longitudinal Study—The COViNEPH Project

A. Dębska-Ślizień, M. Renke, L. Tylicki, 2021, Vaccines.

Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal disease.

W. Hörl, B. Rutkowski, L. Tylicki, 2005, American journal of hypertension.

Aliskiren reduces albuminuria after kidney transplantation.

B. Rutkowski, S. Lizakowski, A. Dębska-Ślizień, 2017, Acta biochimica Polonica.

Management of renin-angiotensin system blockade in patients with chronic kidney disease under specialist care. Retrospective cross-sectional study

B. Rutkowski, S. Lizakowski, D. Świetlik, 2015, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Post-COVID-19 Sydrome and Decrease in Health-Related Quality of Life in Kidney Transplant Recipients after SARS-COV-2 Infection—A Cohort Longitudinal Study from the North of Poland

A. Dębska-Ślizień, L. Tylicki, Z. Heleniak, 2021, Journal of clinical medicine.

Treatment of hypertension in chronic kidney disease patients under specialized care: One-center cross-sectional analyses

B. Rutkowski, S. Lizakowski, D. Świetlik, 2015, Blood pressure.

Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project

A. Dębska-Ślizień, M. Renke, L. Tylicki, 2021, Medicina.

Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.

B. Rutkowski, M. Renke, L. Tylicki, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Addition of aldosterone receptor blocker to dual renin-angiotensin-aldosterone blockade leads to limitation of tubulointerstitial injury of kidney.

B. Rutkowski, M. Renke, L. Tylicki, 2007, Kidney international.

COVID-19 vaccination reduces mortality in patients on maintenance hemodialysis

A. Dębska-Ślizień, L. Tylicki, R. Gellert, 2022, Frontiers in Medicine.

Short-term Effects of Losartan on Cardiovascular Risk and Allograft Injury Biomarkers in Kidney Transplant Recipients.

B. Rutkowski, S. Lizakowski, A. Dębska-Ślizień, 2022, Transplantation proceedings.

Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant Recipients

A. Dębska-Ślizień, M. Renke, L. Tylicki, 2022, Transplantation Proceedings.

High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease.

B. Rutkowski, M. Renke, L. Tylicki, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Significant humoral response to mRNA COVID-19 vaccine in kidney transplant recipients with prior exposure to SARS-CoV-2. The COViNEPH Project.

A. Dębska-Ślizień, M. Renke, L. Tylicki, 2021, Polish archives of internal medicine.

Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial

B. Rutkowski, S. Lizakowski, M. Renke, 2012, International Urology and Nephrology.

Extremely high mortality in COVID-19 hemodialyzed patients in before anty-SARS-CoV-2 vaccination era. The first large database from Poland.

B. Rutkowski, A. Dębska-Ślizień, L. Tylicki, 2021, Polish archives of internal medicine.

Renal Protective Effects of the Renin-Angiotensin-Aldosterone System Blockade: From Evidence-Based Approach to Perspectives

B. Rutkowski, L. Tylicki, Wojciech Larczyński, 2005, Kidney and Blood Pressure Research.

[Pentoxifylline old drug or new hope for nephrology?].

B. Rutkowski, M. Renke, L. Tylicki, 2008, Przeglad lekarski.

Multifactoral analysis of determinators for renal injury in essential hypertension

W. Hörl, B. Rutkowski, L. Tylicki, 2006, Journal of Human Hypertension.

Spironolactone attenuates oxidative stress in patients with chronic kidney disease.

B. Rutkowski, M. Renke, L. Tylicki, 2008, Hypertension.

Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions.

B. Rutkowski, S. Lizakowski, L. Tylicki, 2012, Journal of nephrology.

Pharmacological Nephroprotection in Non-Diabetic Chronic Kidney Disease—Clinical Practice Position Statement of the Polish Society of Nephrology

T. Stompór, M. Adamczak, M. Krajewska, 2023, Journal of clinical medicine.

Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease

B. Rutkowski, A. Dębska-Ślizień, L. Tylicki, 2016, Journal of Nephrology.

Heterologous high dose SARS-CoV-2 mRNA vaccine booster may improve immune response in seronegative kidney transplant recipients

A. Dębska-Ślizień, L. Tylicki, B. Biedunkiewicz, 2022, Archives of medical science : AMS.

Comprehensive Assessment of Eyes in Kidney Transplant Recipients after Recovering from COVID-19

A. Dębska-Ślizień, L. Tylicki, J. Konopa, 2023, Life.

Waning Humoral Response after COVID-19 mRNA Vaccination in Maintenance Dialysis Patients and Recovery after a Complementary Third Dose

A. Dębska-Ślizień, M. Renke, L. Tylicki, 2022, Vaccines.

Tubular injury: the first symptom of hypertensive kidney involvement?

B. Rutkowski, L. Tylicki, J. Manitius, 2003, Medical science monitor : international medical journal of experimental and clinical research.

Changes in Kidney Graft Function in COVID-19 Convalescents

E. Król, A. Dębska-Ślizień, L. Tylicki, 2022, Transplantation Proceedings.

Angiotensin Converting Enzyme Inhibitors May Increase While Active Vitamin D May Decrease the Risk of Severe Pneumonia in SARS-CoV-2 Infected Patients with Chronic Kidney Disease on Maintenance Hemodialysis

A. Dębska-Ślizień, M. Renke, L. Tylicki, 2022, Viruses.

Metabolic disturbances as strong determinator of kidney injury in essential hypertension.

B. Rutkowski, L. Tylicki, 2005, Journal of hypertension.